Al Nahdi Medical Company SCJSC
SAU:4164
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
42.5B BRL |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.1T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY |
Loading...
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
688.6B JPY |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.1B CNY |
Loading...
|
|
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
542.8B JPY |
Loading...
|
|
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
22.7B CNY |
Loading...
|
|
| JP |
|
Sundrug Co Ltd
TSE:9989
|
489.3B JPY |
Loading...
|
Market Distribution
| Min | -6 039.4% |
| 30th Percentile | 4.5% |
| Median | 10.2% |
| 70th Percentile | 19.3% |
| Max | 3 330.3% |
Other Profitability Ratios
Al Nahdi Medical Company SCJSC
Glance View
Al Nahdi Medical Company SCJSC has entrenched itself as a prominent player within Saudi Arabia’s expansive healthcare and retail landscape. Founded in 1986, the company embarked on its journey as a single pharmacy in Jeddah, gradually evolving into the leading pharmacy retail chain in the Kingdom. This evolution is interwoven with the region’s healthcare development, echoing the burgeoning demands of a population increasingly focused on wellness and access to quality health products. Al Nahdi’s strategy hinges on an expansive network of over 1,100 outlets, strategically located not only to ensure accessibility but also to foster strong community ties by providing crucial health services and over-the-counter medications. The company's mission stretches beyond mere business growth; it strives to act as a supportive pillar in the community, exemplified by initiatives such as education programs and promoting public health awareness. Al Nahdi’s business model thrives on diversification and integration within the healthcare supply chain. Core revenue streams derive from retail sales of pharmaceuticals, cosmetics, and personal care products, enhanced by a digital presence that captures the rising trend of online shopping. Their omnichannel strategy, combining physical stores with a robust e-commerce platform, presents a seamless shopping experience tailored to the modern consumer. The company also capitalizes on strategic partnerships and alliances to enhance its product offerings, ensuring that it stays ahead in the competitive landscape. Through its efficient logistics network, Al Nahdi guarantees timely delivery and product availability, which are essential to maintaining customer loyalty and market leadership. This blend of expansive reach, customer-centric service, and strategic foresight not only fuels its profitability but solidifies its position as a healthcare cornerstone across the region.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Al Nahdi Medical Company SCJSC is 9.1%, which is below its 3-year median of 10.3%.
Over the last 3 years, Al Nahdi Medical Company SCJSC’s Operating Margin has decreased from 11.9% to 9.1%. During this period, it reached a low of 9.1% on Jun 30, 2025 and a high of 11.9% on Sep 30, 2022.